ArticleEcancermedicalscience2020
Strengthening capacity for cancer research in conflict settings: key informant insights from the Middle East.
Article in Ecancermedicalscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.
- Cancer and Syria in conflict: a systematic review.BMC cancer · 2024Pooled it
- Patient Concerns Inventory for Arabic Patients with Head and Neck Cancer: A Cross-Cultural Adaptation and Preliminary Validation.Current oncology (Toronto, Ont.) · 2025Article
- Prostate cancer screening in the Middle East and North Africa: a cross-sectional study on current practices.JNCI cancer spectrum · 2025Article
- Characteristics of injuries during the 2006 Lebanon conflict: a three-center retrospective study of survivors, 16 years after the conflict.Frontiers in public health · 2024Article
- Barriers to access to cancer care for patients from the conflict-affected region of the Nagorno-Karabakh Republic: A qualitative study.PLOS global public health · 2024Article
- HealthCare Access Barrier (HCAB) framework for the barriers to cancer care during conflicts: perspective from Iraq.BMJ oncology · 2024Review
- Digital Determinants of Health: Health data poverty amplifies existing health disparities-A scoping review.PLOS digital health · 2023Article
- Article
- Cancer Research in Vulnerable Populations: A Call for Collaboration and Sustainability From MENAT Countries.JCO global oncology · 2023Article
- Editorial: Cancer care in areas of conflict.Frontiers in oncology · 2023Article
- Access to advanced cancer care services in the West Bank-occupied Palestinian territory.Frontiers in oncology · 2023Article
- The state of cancer research in fragile and conflict-affected settings in the Middle East and North Africa Region: A bibliometric analysis.Frontiers in oncology · 2023Article
- The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations.JCO global oncology · 2022Review
- Burden of female breast cancer in the Middle East and North Africa region, 1990-2019.Archives of public health = Archives belges de sante publique · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundManagement of cancer in the Middle East and North Africa (MENA) region is accompanied by multiple challenges including heterogeneous access to early detection and treatment options and limited implementation of national cancer control plans. Furthermore, protracted armed conflicts across the region have had dramatic effects, including disruption of healthcare systems and the migration of healthcare professionals. Strengthening capacity for cancer research has been identified as a key intervention to correct data poverty, inform policy, manage limited resources and improve health outcomes.
objectiveThe main objective of this study is to gain insights into the landscape, barriers and enablers of cancer training, research and care in the MENA region.
methodWe utilised purposive sampling to interview 16 key informants from a diverse academic, medical and research background originating from countries affected by conflicts, such as Lebanon, and from active conflict zones including Iraq and Syria.
resultsThe themes that emerged from the interviews focused on the barriers to cancer care, barriers to cancer research and training, strengths and importance of cancer research and training recommendations. The detrimental effect of conflict on cancer provision and research was a cross-cutting sub-theme disrupting cancer care provision and research due to unsafe environments, fragmented facilities, absence of drugs and migration of personnel. When asked about perceived optimal training format for cancer research, most informants recommended a post-graduate, face-to-face training focusing on cancer research methods and concepts.
conclusionThis study offers a unique insight into the barriers affecting cancer research and capacity-strengthening priorities from oncologists and researchers working in conflict-affected areas of the MENA region. These data will form the base for future capacity-strengthening initiatives addressing specific regional challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.